First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients

BACKGROUND: Serum hepatitis B core-related antigen (HBcrAg) is a potential surrogate marker for intra-hepatic covalently-closed circular DNA in chronic hepatitis B (CHB). We aimed to study the profiles of serum HBcrAg in CHB patients treated with first-line nucleos(t)ide analogues (NA): entecavir (E...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Lung-Yi, Wong, Danny Ka-Ho, Cheung, Ka-Shing, Seto, Wai-Kay, Fung, James, Yuen, Man-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968194/
https://www.ncbi.nlm.nih.gov/pubmed/33731023
http://dx.doi.org/10.1186/s12876-021-01711-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968194/
https://www.ncbi.nlm.nih.gov/pubmed/33731023
http://dx.doi.org/10.1186/s12876-021-01711-x

Ejemplares similares